Yin Yonghui, Li Hui, Chen Yumin, Zhu Ranran, Li Li, Zhang Xinying, Zhou Ji, Wang Zichen, Li Xiaoli
Department of Endocrinology, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Department of Emergency, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Evid Based Complement Alternat Med. 2020 Sep 18;2020:6031782. doi: 10.1155/2020/6031782. eCollection 2020.
Vascular endothelial dysfunction is an essential and early sign of diabetic macroangiopathy, a primary complication of diabetes mellitus. - is a classic medical combination applied in China to treat diabetes mellitus. The aim of this study was to investigate the effect of the granule form of the extract produced from the dried root of (AM) combination with the granule form of the extract produced from the dried (AS) on diabetic macroangiopathy and its underlying mechanism. Herein, rats were treated by AM-AS at a ratio of 3 : 2 via intragastric administration. High glucose-induced human umbilical vein vascular endothelial cells (HUVECs) were then treated with drug-containing serum collected from the rats. In high glucose-treated HUVECs, AM-AS combination increased cell viability ( < 0.05), decreased the percentage of apoptotic cells ( < 0.05) and the expression of the proapoptosis protein caspase 3 ( < 0.05), reduced the proportion of cells in the G0/G1 phase ( < 0.05), decreased reactive oxygen species level ( < 0.05), enhanced cell migration and invasion ( < 0.05), and reduced the level of 8-iso-prostaglandin F2alpha. These results indicate that AM-AS combination at the ratio of 3 : 2 ameliorated HUVEC dysfunction by regulating apoptosis, cell migration, and invasion, which might be mediated by their regulatory effect on reactive oxygen species production. The current study provides a theoretical basis for the treatment of diabetic macroangiopathy using AM-AS.
血管内皮功能障碍是糖尿病大血管病变的一个重要且早期的迹象,糖尿病大血管病变是糖尿病的主要并发症。——是中国用于治疗糖尿病的经典药物组合。本研究旨在探讨由(黄芪)干燥根提取物的颗粒形式与(丹参)干燥根提取物的颗粒形式组成的组合对糖尿病大血管病变及其潜在机制的影响。在此,大鼠通过胃内给药以3∶2的比例接受黄芪-丹参治疗。然后用从大鼠收集的含药血清处理高糖诱导的人脐静脉血管内皮细胞(HUVECs)。在高糖处理的HUVECs中,黄芪-丹参组合增加了细胞活力(P<0.05),降低了凋亡细胞的百分比(P<0.05)和促凋亡蛋白半胱天冬酶3的表达(P<0.05),降低了G0/G1期细胞的比例(P<0.05),降低了活性氧水平(P<0.05),增强了细胞迁移和侵袭能力(P<0.05),并降低了8-异前列腺素F2α的水平。这些结果表明,3∶2比例的黄芪-丹参组合通过调节细胞凋亡、迁移和侵袭改善了HUVEC功能障碍,这可能是由它们对活性氧产生的调节作用介导的。本研究为使用黄芪-丹参治疗糖尿病大血管病变提供了理论依据。